Related Experiment Video
Updated: Mar 4, 2026

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
SLC29A1/ENT1 and SLC29A3/ENT3 differentially regulate autophagy.
Bhawana Bissa1, Tejinder Kaur1, Arnav Joshi1
1Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA.
Equilibrative nucleoside transporters SLC29A1/ENT1 and SLC29A3/ENT3 have opposing roles in autophagy. SLC29A1 inhibits autophagy by regulating adenosine transport, while SLC29A3 promotes it, revealing a complex interplay in cellular homeostasis.
Area of Science:
- Cell Biology
- Molecular Biology
- Physiology
Background:
- Equilibrative nucleoside transporters (ENTs) are crucial for nucleoside salvage, but their diverse roles beyond DNA synthesis remain explored.
- Multiple ENT subfamilies suggest specialized, non-redundant functions in maintaining cellular homeostasis.
- The interplay between ENTs and cellular processes like autophagy is not fully elucidated.
Purpose of the Study:
- To investigate the distinct roles of SLC29A1/ENT1 and SLC29A3/ENT3 in regulating autophagy.
- To elucidate the molecular mechanisms by which these transporters influence autophagic flux.
- To explore the reciprocal regulatory relationship between ENTs and autophagy.
Main Methods:
- Gene silencing (siRNA) to modulate SLC29A1 and SLC29A3 expression.
- Adenosine (Ado) treatment to assess transporter substrate effects.
- Western blotting to analyze PRKAA/AMPK phosphorylation and BECN1-BCL2 interaction.
- Pharmacological inhibition of SLC29A1 transport.
- Analysis of autophagy in prkaa-null cells and slc29a1- /- / slc29a3- /- mice.
Main Results:
- Cell surface SLC29A1/ENT1 inhibits autophagy by suppressing PRKAA/AMPK phosphorylation, contrasting with endolysosomal SLC29A3/ENT3's pro-autophagy role.
- Adenosine treatment induces PRKAA/AMPK-dependent autophagy, with SLC29A1 promoting adenosine efflux and attenuating this effect.
- SLC29A1 inhibits autophagosome formation by promoting BECN1-BCL2 interaction, independent of the MTOR pathway.
- Autophagy reciprocally regulates SLC29A1 and SLC29A3 expression, and corresponding mouse models exhibit altered autophagic activity.
Conclusions:
- SLC29A1 and SLC29A3 play distinct and opposing roles in autophagy regulation.
- SLC29A1's regulation of autophagy is dependent on its nucleoside transport function and cellular metabolic state.
- The findings reveal a dynamic, reciprocal relationship between ENTs and autophagy, offering therapeutic targets for related disorders.
More Related Videos
Related Concept Videos
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Early Endosome: Endocytosis of Transferrin
Intralumenal Vesicles and Multivesicular Bodies
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Lysosomal Hydrolases

